Coal miners, their family members, and union representatives rallied outside of the US Department of Labor’s headquarters in ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...

Gyre Pharmaceuticals has completed participant enrolment for its 52-week Phase III clinical trial assessing Pirfenidone ...

Gyre Therapeutics (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today ...